SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Pre-close Trading Statement

27 May 2015 07:00

RNS Number : 2883O
Ebiquity PLC
27 May 2015
 

Ebiquity Plc

("the Company" or "Ebiquity")

 

 

Pre-close trading statement

 

 

Ebiquity plc, the leading independent marketing analytics specialists, today announces a pre-close trading statement for the full year ended 30 April 2015 (the "year").

 

Ebiquity has enjoyed high single-digit revenue growth on a like for like, constant currency basis. This is the highest in the Company's recent history and shows further acceleration in revenue growth from that reported in the interim results for the year.

 

The Company's Marketing Performance Optimization (MPO) and Media Value Measurement (MVM) divisions, which together account for approximately 65% of total revenues, have both delivered double-digit sales growth (the MPO division alone grew at more than 40%).  We continue to see increasing demand for the services in these two divisions as our clients seek assistance in achieving greater data transparency and improved marketing performance.

 

The Company's Market Intelligence (MI) division operates in a highly competitive market and we continue to see revenue impacted, but at a slower rate than in the year ended April 2014 ("last year"). As we stated in our interim results, during the course of the year wecommenced an enhancement programme to the division's services and delivery platform, which continues into the year which started on 1 May 2015 (the "current year"). Once completed, we expect this programme to return the division's revenues to modest growth.

 

During the year we made significant investments in both people and technology in order to drive greater, sustainable revenue growth across the group. This is already proving successful with stronger top-line growth and several significant new business wins in the final quarter of the year. The majority of revenues from these wins however will be recognised in the current year and, given the investments mentioned above, this is likely to result in some softening of margins for the year.

 

The Company expects in the second half of the year a similar adverse foreign exchange rate impact on profit before tax as in the first half of the year. However, profit before tax for the year on a constant currency basis will be in line with the Board's expectations.

 

We continue to see positive client engagement and increasing contract sizes. We begin the current year with a very strong pipeline of new business and high visibility over the Company's revenue targets for the current year.

 

The Board continues to have great confidence in the Company's future and will be making a recommendation for the Company's maiden dividend when it reports the final results for the year on 29 July 2015.

 

 

27 May 2015

 

Enquiries:

 

Ebiquity plc

Michael Greenlees (CEO)

Andrew Beach (CFOO)

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

020 7650 9600

 

 

 

020 7457 2020

Numis Securities Limited

Nick Westlake (NOMAD)

David Poutney, James Serjeant (Corporate Broker)

020 7260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEAKSKADNSEFF
Date   Source Headline
9th Sep 20167:00 amRNSAppointment of CFO and Director
6th Sep 20167:00 amRNSLaunch of new Advertising Intelligence platform
27th Jul 20167:00 amRNSTrading Statement
19th Jul 20167:30 amRNSGuidelines for achieving media transparency
19th Jul 20167:00 amRNSRe: Directorate
12th Jul 201611:45 amRNSTR-1: Notification of Major Interest in Shares
22nd Jun 201611:05 amRNSTR1
9th Jun 20161:50 pmRNSCapital Reduction effective
8th Jun 201611:40 amRNSCourt confirmation of Capital Reduction
3rd Jun 20163:50 pmRNSDirector dealing
20th May 20167:00 amRNSHolding(s) in Company
19th May 20162:25 pmRNSHolding(s) in Company
11th May 201611:20 amRNSAGM resolutions passed
11th May 20168:50 amRNSExercise of Share Options
29th Apr 20165:30 pmRNSRe Directorate
25th Apr 201610:45 amRNSHolding(s) in Company
15th Apr 20163:40 pmRNSAnnual Report
30th Mar 20167:00 amRNSFinal Results
27th Jan 20167:00 amRNSAppointment of Director and Director Dealing
27th Jan 20167:00 amRNSInterim Results
8th Jan 201611:27 amRNSHolding(s) in Company
26th Nov 20157:00 amRNSTrading Statement
25th Nov 20152:41 pmRNSDirector Dealing
9th Nov 201512:15 pmRNSCORRECTION - Holding(s) in Company
9th Nov 201510:21 amRNSHolding(s) in Company
6th Nov 201511:53 amRNSHolding(s) in Company
15th Oct 20157:10 amRNSExercise of Share Options
15th Oct 20157:00 amRNSAppointment of director
12th Oct 20152:21 pmRNSDirector Dealing
2nd Oct 20157:00 amRNSDirector Dealings
1st Oct 20157:00 amRNSBoard changes
22nd Sep 20154:48 pmRNSExercise of Share Options
17th Sep 20157:00 amRNSFinal dividend for the year ended 30 April 2015
15th Sep 20153:33 pmRNSResult of AGM
17th Aug 20157:00 amRNSAnnual Financial Report
28th Jul 20157:10 amRNSChange in financial year end
28th Jul 20157:00 amRNSFinal Results
6th Jul 20155:56 pmRNSHolding(s) in Company
25th Jun 201512:15 pmRNSHolding(s) in Company
24th Jun 20154:22 pmRNSHolding(s) in Company
24th Jun 20157:00 amRNSChange to final results announcement date
9th Jun 20154:13 pmRNSHolding(s) in Company
8th Jun 20152:43 pmRNSHolding(s) in Company
8th Jun 201511:10 amRNSHolding(s) in Company
1st Jun 201510:37 amRNSExercise of Share Options
27th May 20157:00 amRNSExercise of Share Options
27th May 20157:00 amRNSPre-close Trading Statement
22nd May 20155:15 pmRNSHolding(s) in Company
19th May 20157:00 amRNSExercise of Share Options
16th Mar 20154:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.